Ads
related to: alpha-1
Search results
Morgan Stanley's deep dive on AI's rate of change By Investing.com
Investing.com· 4 days agoIn a recent report, Morgan Stanley delved into the rapidly evolving landscape of AI's integration...
Fidelity believes investors should consider small Bitcoin exposure for long-term portfolios
CryptoSlate· 6 days agoFidelity Investments believes that a modest Bitcoin (BTC) allocation could benefit investors...
Byju's US subsidiary lenders drag more entities into bankruptcy
Investing.com· 7 days agoCreations Inc. and Tangible Play Inc. to Chapter 11 of the US Bankruptcy Code to...
Inhibrx (NASDAQ:INBX) Trading Up 2% on Insider Buying Activity
ETF DAILY NEWS· 3 days agoShares of Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) were up 2% during mid-day trading on Friday following insider buying activity. The company traded as high as $16.57 and last traded at ...
Legacy Health Endowment, Hello Alpha to Provide Free Virtual Healthcare in 2 California Counties
PRWeb· 4 days agoSpecially designed to meet the needs of "the forgotten middle," Sonja Cares is an innovative solution for accessible, equitable healthcare. The forgotten middle is made up of individuals and ...
Capital Research Global Investors Sells 509,361 Shares of Inhibrx, Inc. (NASDAQ:INBX)
ETF DAILY NEWS· 5 days agoCapital Research Global Investors trimmed its position in Inhibrx, Inc. (NASDAQ:INBX – Free Report) by 41.7% during the fourth quarter, according to the company in its most recent 13F filing ...
52,810 Shares in Grifols, S.A. (NASDAQ:GRFS) Bought by Campbell & CO Investment Adviser LLC
ETF DAILY NEWS· 3 days agoCampbell & CO Investment Adviser LLC purchased a new stake in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities ...
Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at...
Benzinga· 5 days agoOcuphire Pharma, Inc. OCUP ("Ocuphire"), a clinical-stage biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye ...
